Announcements Trials
Browse Landscape

Status

Withdrawn 1Unknown 1Terminated 1Recruiting 1Completed 1

Sponsor Class

OTHER 4INDUSTRY 1

Study Type

Observational 5

Sponsor

Cancer Type

Tumor-Agnostic 2Other hematologic neoplasm 1CNS 1

Conditions

Neoplasms 5Ovarian Neoplasms 3Lung Neoplasms 3Breast Neoplasms 3Prostatic Neoplasms 2Lymphoma 2Head and Neck Neoplasms 2Colorectal Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Brain Neoplasms 2Adenocarcinoma 2Urticaria 1Tuberous Sclerosis 1Squamous Cell Carcinoma of Head and Neck 1Small Cell Lung Carcinoma 1Severe Combined Immunodeficiency 1Salivary Gland Neoplasms 1Renal Insufficiency, Chronic 1Rectal Neoplasms 1Pancreatitis, Chronic 1Pancreatitis 1Pancreatic Cyst 1Non-alcoholic Fatty Liver Disease 1Neuroendocrine Tumors 1Neuroblastoma 1Nephritis 1Neoplasm Metastasis 1Multiple Sclerosis 1Mucopolysaccharidosis I 1Melanoma 1

Interventions

Surveys and Questionnaires 86Blood Specimen Collection 58Interviews as Topic 28Observation 15Data Collection 15Radiotherapy 12Watchful Waiting 11Magnetic Resonance Spectroscopy 11Hematologic Tests 11Exercise 11Drug Therapy 11Quality of Life 9Biopsy 8Specimen Handling 7Therapeutics 6Restraint, Physical 6Magnetic Resonance Imaging 6Focus Groups 6pembrolizumab 5Standard of Care 5Rivaroxaban 5Phlebotomy 5Nivolumab 5Lapatinib 5Immune Checkpoint Inhibitors 5atezolizumab 4apixaban 4Trastuzumab 4Patient Reported Outcome Measures 4Palliative Care 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Observational × Neoplasms × Phlebotomy × Clear all
NCT07121998 2025-08-14

PROGRESS-TMZ

Uppsala University

Recruiting
94 enrolled

Endocrine Gland Neoplasms, Neoplasms

NCT00695279 2024-10-30

Long Term Follow Up Of Patients Who Have Received Gene Therapy Or Gene Marked Products

St. Jude Children's Research Hospital

Completed
41 enrolled
CNSOther hematologic neoplasm

Mucopolysaccharidosis I, Neoplasms, Neuroblastoma, Severe Combined Immunodeficiency, Hematologic Neoplasms

NCT03884400 2022-11-14

Distribution of Biospecimens From Biorepositories/Biobanks for Research Use

iSpecimen Inc

Withdrawn

Autoimmune Diseases, Digestive System Diseases, Neoplasms, Nephritis

NCT00507702 2019-04-18

Identification of Key Blood Molecular Markers for Immunotherapy

Stanford University

Terminated
191 enrolled
Tumor-Agnostic

Adenocarcinoma, Carcinoma, Squamous Cell, Neoplasms

NCT02874729 2016-11-25

Assay Development for Cancer Biomarkers

King's College London

Unknown
400 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡